Last Price
1.01
Today's Change
-0.04 (3.80%)
Day's Change
0.993 - 1.04
Trading Volume
506,491
Profile
LUCD
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Lishan Aklog M.D. Dr. Lishan Aklog M.D.
Full Time Employees: 70 70
IPO Date: 2021-10-14 2021-10-14
CIK: 0001799011 0001799011
ISIN: US54948X1090 US54948X1090
CUSIP: 54948X109 54948X109
Beta: 1.42 1.42
Last Dividend: 0.00 0.00
Dcf Diff: 1.97 1.97
Dcf: -0.92 -0.92
Description
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
2
CEO Morning Brief
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
3
CEO Morning Brief
Dogecoin Outperforms Bitcoin as Trump Spurs Crypto Speculation
4
CEO Morning Brief
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
